2018. Start Activity
4 Nov 2015 The American Society of Clinical Oncology (ASCO) updated their antiemetic guideline to include the use of a novel antiemetic combination for cancer patients. 1.
1 Aug 2017 The American Society of Clinical Oncology (ASCO) has updated its guidelines on medicines to control nausea and vomiting in people being treated for cancer. The update was published online on July 31, 2017 by the Journal of Clinical Oncology. Read the abstract of “Antiemetics: American Society of
Annually, ASCO will review guideline topic proposals from ASCO members. To submit a topic for consideration, access our survey. Please note the submission period for 2016-2017 topics has closed and any topic submissions will be considered for prioritization in Fall 2017. ASCO guidelines are reviewed for their currency
25 Oct 2017 AS REPORTED BY Paul J. Hesketh, MD, of Lahey Hospital and Medical Center, Burlington, Massachusetts, and colleagues in the Journal of Clinical Oncology, ASCO has updated its clinical practice guideline on the use of antiemetics in patients with cancer.1 The update was based on an expert panel
31 Jul 2017 To update the ASCO guideline for antiemetics in oncology. Methods. ASCO convened an Expert Panel and conducted a systematic review of the medical literature for the period of November 2009 to June 2016. Results. Forty-one publications were included in this systematic review. A phase III randomized
July 31, 2017. The American Society of Clinical Oncology (ASCO) has fully updated its antiemetic guideline for patients with cancer receiving chemotherapy and radiation therapy for the first time since 2015. The update is published online in the Journal of Clinical Oncology. Most notably, the guideline provides new
2 Aug 2017 ASCO has updated its clinical guidelines for antiemetic therapy in patients receiving chemotherapy.

Annons

The photo has no tags

March 2018